Overview
Fathom Therapeutics is a drug design company that uses physics-based simulations and AI to design novel small molecules by modeling protein motion at atomic resolution.[1] Founded in 2023,[3] the company is headquartered at 420 Lexington Ave, New York, New York, 10170.[4]
Business address: 420 Lexington Ave, New York, New York, 10170. [4]
Funding & milestones
1 events found for Fathom Therapeutics · 2026
Series AVenture / equityDetails$47M
Reported amount $47,000,000
Source not attached to this recordDeal record
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Key people
Backers
Chemistry
San Francisco early-stage venture firm founded by investors from Bessemer, a16z and Index, investing in AI and automation, fintech, healthcare and physical intelligence.
- AVAlexandria Venture Investments
- SHSutter Hill Ventures
- ESEmpire State Development’s NY Ventures
Something wrong or missing? Send an update. Fixed within 24 hours.